| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |